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Abstract 
Diabetic peripheral neuropathy (DPN) affects up to half of those with type 2 diabetes 
mellitus. Chronic neuropathic pain, a common symptom of DPN, remains difficult to treat 
pharmacologically. Mindfulness-based stress reduction (MBSR) has demonstrated benefits in 
chronic pain populations and a recently completed randomized controlled trial demonstrated 
improved function among patients with DPN who completed the program. The present study 
used archival data from this recently completed trial, with 62 participants (Mean age = 59.7 
years, SD = 8.8). It was predicted that improved function following MBSR training would be 
explained by increased mindfulness and a reduction of pain catastrophizing. Mediation analysis 
indicated that while mindfulness was a mediator, pain catastrophizing was not, when controlling 
for baseline scores. This suggests that MBSR may improve function through self-awareness and 
one's ability to engage in the present moment non-judgmentally, rather than through one’s ability 
to control and reduce pain-related catastrophic cognitions. 
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Introduction 
Neuropathic Pain & Diabetes 
Diabetes mellitus is a medical condition that impacts up to 12.9% of North Americans 
(Guariguata, Whiting, Weil, & Unwin, 2011) and leads to many long term complications such as 
retinopathy (potential loss of vision), nephropathy (leading to renal failure), foot ulcers and 
peripheral neuropathy (Genuth et al., 2003). Chronic neuropathic pain, a common symptom of 
diabetic peripheral neuropathy, is challenging to treat and it is often related to poor health 
outcomes and a reduced quality of life (Boulton et al., 2005). Between 26% and 50% of patients 
with type 2 diabetes have been diagnosed with diabetic peripheral neuropathy, while up to 25% 
of those patients will develop neuropathic pain as a result (Van Hecke, Austin, Khan, Smith, & 
Torrance, 2014; Tesfaye et al., 2011). 
Neuropathic pain is typically caused by a lesion or dysfunction within the nervous 
system, either centrally or peripherally (Merskey & Bogduk, 1994). In the case of diabetes, 
poorly controlled blood glucose level can lead to nerve damage, often affecting nerve endings in 
the hands and feet (Adler et al., 1997). In addition to its etiology, what distinguishes neuropathic 
pain from other types of pain are its characteristic symptoms that can be described as burning, 
electric shocks, shooting pain or uncomfortable tingling/numbness (paresthesia). To provide 
context of what this experience is like, patients with neuropathic pain have described the 
sensation as ‘walking barefoot on hot sand or marbles’ (Tesfaye et al., 2011). Allodynia is also 
common; it is a painful sensation caused by seemingly innocuous stimuli such as light touch or 
contact with fabric. This can happen during daily activities such as putting on socks or being 
covered by a blanket or sheet (Lolignier, Eijkelkamp, & Wood, 2015). Clinical features such as 
paresthesia and allodynia are often experienced in parts of the body which may appear otherwise 
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normal and healthy, making diagnoses difficult (Tesfaye et al., 2011). This creates challenges in 
coping and in treatment that are unique to neuropathic conditions.  
Neuropathic forms of pain are particularly difficult to treat as they tend to be resistant to 
many commonly prescribed analgesics (Gilron, Watson, Cahill, & Moulin, 2006). Evidence has 
shown that pharmacological treatment provides only partial relief of the pain at best, while often 
resulting in adverse effects that also reduce quality of life. Common side effects of tricyclic 
antidepressants and anticonvulsants include adverse cardiac effects, insomnia, drowsiness and 
dizziness. More severe risks may be associated with the prescription of opioids including 
possible seizures, respiratory depression and cognitive dysfunction (Gilron et al., 2006; Tesfaye 
et al., 2011). Additionally, the majority of recommended treatment approaches for neuropathic 
pain in diabetes treat the symptoms, and are not expected to improve the condition itself (Tesfaye 
et al., 2011). 
The limited advances in the treatment of neuropathic pain, including painful diabetic 
peripheral neuropathy, mean that those who are affected must learn to cope with the symptoms 
and impairment associated with them. In reviewing the literature pertaining to neuropathic pain 
and health-related outcomes, Jensen, Chodroff, and Dworkin (2007) provided unequivocal 
evidence that neuropathic pain negatively impacts patients’ quality of life. Specifically, the 
severity of neuropathic pain is negatively related to the magnitude of its interference with 
physical, emotional and social functioning, and it is often associated with sleep problems, all 
leading to reduced overall health-related quality of life (Jain, Jain, Raison, & Maletic, 2011). In a 
study of 495 patients with moderate to severe diabetic peripheral neuropathy, nearly a quarter of 
participants met criteria for depression at baseline, increasing to 28.4% after 18 months and those 
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higher in depressive symptoms were more likely to have severe restrictions in their daily 
activities (Vileikyte et al., 2009).  
The presence of associations between neuropathic pain and all aspects of functioning 
suggests that a biopsychosocial approach is crucial to understanding the characteristics, 
development and treatment of the condition. Other forms of pain have been examined through 
this lens (Melzack & Katz, 2006), which has led to interdisciplinary treatment which take 
psychological and environmental factors into account, beyond the traditional pharmacological 
approach.  
The Fear-Avoidance Model of Chronic Pain 
Contrary to early biomedical theories that explained pain as a purely sensory event in which 
pain intensity was thought to provide a good proxy for tissue damage alone, it is now understood 
that pain is a subjective experience. The perception of pain is influenced by bidirectional neural 
pathways that carry sensory information. These pathways are influenced by emotional and 
cognitive information that can inhibit or expedite the transmission of a painful stimuli to the 
brain. This means that there is not a direct relationship between tissue damage or injury and the 
perception of pain since the signal can be influenced by psychosocial information beyond 
biological mechanisms (Melzack, 2001). Gaining an understanding of the subjective factors that 
impact the experience of pain may lead to more effective treatments. This is particularly true for 
those with neuropathic forms of pain, given the limited advances in treatment and the impact of 
the symptoms on daily life.  
The well-supported fear-avoidance model of chronic pain as described by Vlaeyen and 
Linton (2000) explains how fear plays a role in the development of pain-related disability and 
other influential variables within the cycle. Pain-related fear has been conceptualized as fear of 
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experiencing pain, fear of activities that may elicit pain, or fear of movements which may 
(re)injure the individual. Within this framework, confrontation and avoidance lie on opposite 
ends of the spectrum in terms of how one might respond to the fear of pain. Confronting pain-
related fear should lead to a decrease in fear over time and more desirable health and 
psychological outcomes. Conversely, avoidance of pain sensations and cognitions may lead to a 
phobic state, in which fear-related processes, such as pain catastrophizing, negative affect and 
hypervigilance, contribute to further fear avoidance and consequent functional disability 
following disuse.  
Although pain-related fear may have a purpose in situations in which the avoidance of 
movement serves to prevent further injury and allow time to heal, total avoidance of movement 
or physical activity is maladaptive over time, and will lead to impaired function, and more 
negative mood and psychological symptoms  (Fujii, Matsudaira, & Oka, 2013; Pinto et al., 
2014). This is thought to occur as pain-related fear is negatively reinforced by avoidance 
behaviours. In other words, although the avoidance of fearful stimuli such as moving a limb that 
is in pain may reduce fear in the short term, it may increase the fear response, or anticipation of 
pain over the long term, potentially leading to a phobic state. Therefore, a mutual reinforcement 
of avoidance behaviours and pain-related fear may contribute to the development of disability 
(Vlaeyen & Linton, 2000).   
One of the advantages of understanding the experience of pain through the fear-avoidance 
model is that it is a dynamic framework, constantly updated based on emerging evidence (Zale & 
Ditre, 2015). For example, in 2000, Vlaeyen and Linton did not consider pain intensity to be a 
vital component of the model. However, after several studies concluded that pain intensity is a 
threatening experience which drives escape and avoidance behaviours, it is considered a 
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predictive factor of disability, and as such, has been integrated into the model (Leeuw et al., 
2007). Additionally, the model has been validated and supported using rigorous methods such as 
structural equation modeling with a large sample size (Cook, Brawer, & Vowles, 2006), 
providing further evidence for its use in understanding biopsychosocial perspectives of pain. 
A limitation of our current understanding of the fear-avoidance model is that although it has 
been tested many times in samples with musculoskeletal or mixed-pain conditions (Cook et al., 
2006; Leeuw et al., 2007; Vlaeyen & Linton, 2000), few have studied how the framework 
applies in neuropathic conditions. A cross-sectional study by Poulin et al. (2016) confirmed that 
pain catastrophizing significantly predicted pain intensity, pain-related disability as well as 
depression in cancer survivors with neuropathic pain. de Jong et al. (2005) looked at pain-related 
fear and disability in a group of patients with complex regional pain syndrome, although small 
sample size (N = 8) and lack of longitudinal data reflect similar problems across the few studies 
that have assessed neuropathic conditions. It seems intuitive that there would be similarities in its 
application across pain conditions (Leeuw et al., 2007), but this needs to be empirically tested.  
The notion that the fear of pain may become more disabling than the pain itself has led 
researchers to investigate which variables might present influencing roles in this process and 
ideally increase the likelihood of confronting pain-related fear. Of note, pain catastrophizing is 
considered a key variable in the fear-avoidance model based on its predictive ability in relation 
to other pain-related outcomes. Pain catastrophizing can be described as a negative cognitive 
orientation towards pain (Sullivan, Bishop, & Pivik, 1995).  
A commonly used measure for pain catastrophizing is the Pain Catastrophizing Scale 
(Sullivan et al., 1995). In this scale, pain catastrophizing is conceptualized in three separate 
dimensions which are helplessness, rumination and magnification. It also provides a total 
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catastrophizing score. Support for including pain catastrophizing in the fear avoidance model 
includes a study by Pavlin, Sullivan, Freund & Roesen, (2005), who demonstrated that those who 
are more prone to pain catastrophizing were more likely to experience higher pain intensities and 
levels of disability in the weeks following surgery. Additionally, catastrophizing is related to the 
chronicity of pain, as shown by Forsythe et al. (2008), who found that within a group of arthritis 
patients, those who had higher tendencies to catastrophize in relation to their pain, were more 
likely to experience persistent pain and disability up to two years following knee-replacement 
surgery.  
Examining pain catastrophizing in neuropathic forms of pain, in a sample of patients with 
fibromyalgia, catastrophizing predicted self-reported pain-related behaviours and coping 
strategies both before and after clinical intervention (Nicassio, Schoenfeld-Smith, Radojevic, & 
Schuman, 1995). Additionally, a number of studies have linked pain catastrophizing to disability, 
including those with neuropathic forms of pain such as sensory neuropathy (Lucey et al., 2011) 
and mixed neuropathic pain diagnoses (Arnow et al., 2011; Sullivan, Lynch, & Clark, 2005), 
with Sullivan et al. concluding that catastrophizing predicted pain-related disability more so than 
pain intensity. Research findings have situated pain catastrophizing as a crucial factor in 
understanding chronic pain and how it might impact related factors such as pain intensity and 
disability. 
The detrimental effects of pain catastrophizing in relation to both pain and psychosocial 
function raises the question of which positive coping mechanisms might interrupt the negative 
fear-avoidance cycle and how might they be implemented. A revised model of fear-avoidance 
and chronic pain has proposed that the relationship between pain intensity and pain 
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catastrophizing can be moderated through mindfulness (Schütze, Rees, Preece, & Schütze, 
2010). 
Mindfulness & the Fear-Avoidance Model 
Mindfulness has been described as the ability to maintain a moment-to-moment, non-
judgmental awareness of our experiences (e.g., thoughts, bodily sensations and emotions; Kabat-
Zinn, 1990). Moreover, mindfulness-based interventions conceptualize mindfulness as a skill 
that can be learned and practiced over time. Mindfulness-based stress reduction (MBSR) was 
first developed by Kabat Zinn (1982) as a group program for those with chronic illness who were 
not responding to standard medical treatments. It focuses on improving awareness and 
acceptance of moment-to-moment experiences, including physical discomfort and negative 
emotions. These interventions have been shown to result in reduced psychological symptoms and 
improved health and well-being among different clinical and non-clinical groups (Carmody & 
Baer, 2008; Grossman, Niemann, Schmidt, & Walach, 2004; Khoury et al., 2013; Veehof, 
Oskam, Schreurs, & Bohlmeijer, 2011). 
Although mindfulness-based interventions have been applied to many different 
conditions and demographics, their effectiveness has been demonstrated in many randomized 
trials including reducing depression (Sephton et al., 2007) and improving health-related quality 
of life (Schmidt et al., 2011) among women with fibromyalgia, reducing psychological distress 
in rheumatoid arthritis patients (Pradhan et al., 2007), as well as improving pain acceptance, 
function and quality of life in failed back surgery syndrome patients (Esmer, Blum, Rulf, & Pier, 
2010). In a systematic review by Veehof and colleagues (2011) consisting of controlled and 
uncontrolled mindfulness and acceptance based interventions, moderate effect sizes were found 
for pain intensity, depression, anxiety, physical well-being and quality of life. 
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In terms of an operational definition, mindfulness is considered to be a multi-faceted 
construct (Baer, 2006). Given its complex nature, consensus has not yet been achieved on how to 
operationalize and measure it. Kabat-Zinn’s definition drew primarily from Buddhist and yogic 
teachings. Alternative operational definitions have included components of self-regulation of 
attention, focusing on the present moment, and maintaining curiosity, openness and acceptance 
of the present moment (Bishop et al., 2006).  
 Baer and colleagues sought to operationalize the individual facets of mindfulness. This 
was accomplished through examining the psychometric properties of five prominent, self-report 
mindfulness questionnaires which included the Mindful Attention Awareness Scale (Brown & 
Ryan, 2003), the Freiburg Mindfulness Inventory (Walach, Buchheld, Buttenmüller, 
Kleinknecht, & Schmidt, 2006), the Kentucky Inventory of Mindfulness Skills (R. A. Baer, 
Smith, & Allen, 2004), the Cognitive and Affective Mindfulness Scale (Feldman, Hayes, Kumar, 
Greeson, & Laurenceau, 2007) and the Mindfulness Questionnaire (Chadwick, Hember, Mead, 
Lilley & Dagnan, 2005). After evaluating the factor structure of the combined items, they 
compiled a comprehensive five-facet conceptualization of mindfulness. This structure includes 
observing, describing, acting with awareness, non-judgment and non-reactivity to experiences.  
Observing refers to one’s ability to notice or attend to internal or external experiences. 
Describing refers to one’s ability to label internal experiences with words and descriptions. 
Acting with awareness refers to one’s ability to attend to what is occurring in the present moment 
in contrast to automaticity or running on ‘autopilot’. Non-judgment refers to approaching one’s 
thoughts and feelings in a non-evaluative way.  Finally, non-reactivity towards inner experiences 
refers to the tendency to allow thoughts and feelings to come and go without getting caught up in 
a particular experience.  
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Many mindfulness researchers posit that the central mechanisms of action in 
mindfulness-based interventions is thought to be increased mindfulness itself (Baer, Smith, 
Hopkins, Krietemeyer, & Toney, 2006). However, it has yet to be established if increased 
mindfulness is the sole determinant of health improvements following the intervention (Harrison, 
Scott, Johns, Morris, & McCracken, 2017), or if other psychosocial factors such as a reduction in 
pain catastrophizing, are the mechanisms through which therapeutic effects are seen. 
This first study to look at pain catastrophizing and mindfulness was conducted by 
Schutze et al. (2010). They examined how mindfulness related to various aspects of the fear-
avoidance model of chronic pain and found that it negatively predicted pain intensity, negative 
affect, pain catastrophizing, pain related fear, pain hypervigilance and functional disability. 
Additionally, they found that mindfulness moderated the relationship between pain intensity and 
pain catastrophizing. The authors explain this effect by describing mindfulness as a type of 
attention that is ‘at odds’ with the cognitive components associated with pain catastrophizing 
such as judgement, automatic, conceptual processing and rumination. By counteracting these 
negative thought patterns through accepting practices, mindfulness is thought to facilitate more 
realistic and non-judgmental cognitions related to pain.   
Cassidy, Atherton, Robertson and Walsh’s (2012) study of low back pain patients both 
supported the relationships established in Schutze et al.’s study, but also found that both 
mindfulness and pain catastrophizing changed significantly following a cognitive-behavioural 
pain management program. Although this program was not mindfulness-based, it still encourages 
the notion that interventions targeting unhelpful thinking styles may be able to produce 
comparable results for patients by increasing levels of mindfulness and reducing catastrophic 
thoughts regarding pain. Comparable relationships were found in a study which evaluated the use 
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of a mindfulness-based meditation program via videoconferencing, in which both those in a live 
class and those in a distance education program achieved similar improvements in both mental 
health and pain catastrophizing (Gardner-Nix, Backman, Barbati, & Grummitt, 2008). 
A limitation found in past research that has examined the relationship between 
mindfulness and pain catastrophizing is the use of a uni-dimensional measure of mindfulness, 
specifically the use of the Mindful Attention Awareness Scale (MAAS; Brown & Ryan, 2003). 
In the development of a multi-faceted model of mindfulness, Baer et al. (2006) found that the 
items from Brown and Ryan’s scale loaded solely onto the acting with awareness facet.  
Both Schutze et al. and Cassidy et al.’s use of the Mindful Attention Awareness Scale is 
limiting in the sense that it has been established that mindfulness is a complex, multi-faceted 
construct, and should therefore be measured as such. Additionally, the MAAS has shown to be 
less reliable than more comprehensive means of measurement (Park, Reilly-Spong, & Gross, 
2013).  Some studies, in focusing primarily on clinical outcomes, have not measured mindfulness 
at all (Gardner-Nix et al., 2008). These methods illustrate a gap in the research in terms of 
investigating the role of mindfulness in non-musculoskeletal pain, using a comprehensive 
measure of mindfulness. 
Nathan and colleagues (under review) addressed these limitations and recently completed 
a randomized controlled trial comparing the effects of medical management alone compared to 
medical management combined with mindfulness-based stress reduction for patients with painful 
diabetic peripheral neuropathy. They demonstrated that those in the MBSR group experienced a 
significant decrease in pain interference (41.4%) three months following the intervention 
compared to the control group, as well as improvements in both pain catastrophizing and 
mindfulness. Using archival data from Nathan et al., the current study will explore how pain 
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catastrophizing and mindfulness might explain how mindfulness-based interventions work in this 
population.  
Objectives 
The primary objective of this study is to explore the influencing role mindfulness and 
pain catastrophizing have on disability throughout a MBSR program in those with diabetic 
peripheral neuropathy. Of all the components illustrated in Vlaeyen’s fear-avoidance model, 
attention is paid to pain catastrophizing, as this is understood to be the cognitive route through 
which the fear of pain develops (Vlaeyen, Kole-Snijders, Boeren, & van Eek, 1995). Sullivan et 
al. (2001) notes that much of the research examining the relationship between pain and 
catastrophizing has been cross-sectional. This study examines it over the course of an 
intervention and at follow up. 
Second, much of research that has applied the fear-avoidance model has used either non-
specified (Schutze et al., 2010) or musculoskeletal chronic pain conditions (Cassidy et al., 2012). 
Presently, the role of pain catastrophizing and mindfulness in relation to pain-related disability 
has not been explored in those with painful diabetic peripheral neuropathy participating in a 
mindfulness-based stress reduction program. The role of the current study is to assess if these 
key variables may explain the impact the intervention has on pain-related disability. 
Hypotheses 
This current analysis is an attempt to understand why a reduction in pain interference 
occurs over the course of a mindfulness-based stress reduction program and through what 
mechanisms the intervention is effective. Studies have shown that greater pain catastrophizing is 
related to higher levels of disability in pain-related conditions (Forsythe et al., 2008; Pavlin, 
Sullivan, Freund, & Roesen, 2005), and higher mindfulness predicts lower pain catastrophizing 
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(Cassidy et al., 2012; Schütze et al., 2010), but the effects of the two constructs on pain-related 
disability have not yet been compared simultaneously. It is predicted that participating in the 
intervention will reduce pain interference as a result of its relationship with pain catastrophizing. 
Through similar mechanisms, mindfulness is also expected to mediate the effects of participating 
in MBSR and pain interference. These hypotheses will be tested in a parallel mediation model. 
Sequential analysis to determine if mindfulness influences pain catastrophizing, thereby 
reducing pain-related disability was not possible given the restricted number of time points 
variables were measured (Hayes, 2013). 
Methods 
Design 
This study was conducted using archival data that has been previously collected at The 
Ottawa Hospital Pain Clinic as part of a large randomized control trial comparing mindfulness-
based stress reduction to a wait-list control among patients with painful peripheral diabetic 
neuropathy, referred to from this point forward as the primary study (Nathan et al., 2017, under 
review). The primary study was a registered clinical trial with the National Institutes of Health 
(Registration #NCT02127762) and was approved by the Ottawa Hospital Health Sciences Centre 
Research Ethics Board (Approval Number # 20120541-01H). Funding in support of this study 
was received from the Canadian Diabetes Association. The current archival study presents a 
subset of this data and was conducted after the primary analysis had been completed. 
Participants 
The primary study recruited patients by telephone from a database of patients attending 
the Ottawa Hospital Endocrine and Diabetes Centre who had consented to be contacted for 
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research projects. Some patients were also referred to the study by diabetes healthcare team 
members in the Ottawa community. 
The primary study enrolled men and women over 18, and included adults with Type 1 or 
Type 2 Diabetes Mellitus regardless of whether or not they were receiving insulin. Additionally, 
they had to have demonstrated good glycemic control (HbA1c 6.5-9), and had been diagnosed 
with diabetic peripheral neuropathy for at least one year. Patients were eligible to participate if 
they had experienced pain for longer than 6 months, with moderate to severe levels of pain 
intensity, which equates to a mean score of 4 or greater on a visual analogue scale (VAS) from 
zero to nine. Patients responding “yes” to 3 or more of the 7 subjective items on the neuropathic 
pain scale were asked to rate their pain on a VAS scale (0-9) at the same time each day for 7 
consecutive days.  Each day they filled out 2 VAS scales: one for pain at rest and one for pain 
with activity.  Patients were included only if the mean score for one or other scale was 4 or 
greater.  Patients were excluded if they had previously participated in a mindfulness-based 
workshop or group before. 
Sample size was determined in the primary study to achieve 80% power to detect a 
minimally important absolute difference of 30% in the intervention group, compared to the 
control. These assumptions indicated that a sample size of 80 participants were required. The 
primary study planned to recruit 94 patients (47 patients in each group, accounting for 15% 
attrition). Recruitment stopped after 66 patients were enrolled due to exhaustion of funds.  
Two hundred and fifty individuals were screened for eligibility. Thirty-one participants 
were randomized to the mindfulness-based stress reduction program, while 33 were randomized 
to the wait-list control group. Thirty participants from the MBSR group and thirty-two from the 
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wait-list control group completed the follow up questionnaire and were included in analysis (See 
Appendix A).  
Participants’ ages (years) ranged from 35-79 in both groups and the mean age was 59.7 
(SD = 8.8). Half of the participants in the treatment group were retired, while the other half were 
generally evenly split between being either employed or on disability. Similarly, 56.3% of 
participants in the control were retired, while 25.0% were on disability and 12.5% were 
employed. Further details will be provided in the descriptive statistics section in Results.   
Procedure 
After meeting eligibility criteria and providing informed consent, participants were first 
offered medical management to optimize pain control, working with an interdisciplinary team at 
the Ottawa Hospital Pain Clinic. This phase lasted a minimum of 3 months and up to 5 months. 
Optimal pharmacological management was based on two consensus statements made regarding 
the evidence-based treatment of painful diabetic peripheral neuropathy (Bril et al., 2011; Tesfaye 
et al., 2011). After confirming that patients were on a stable drug regiment for at least 3 weeks, 
they were randomized into either the intervention group or a wait-list control group. Patients 
were discouraged from making any changes to their medication regimen during the time of the 
study. Patients in the control group were offered the ability to participate in a MBSR course 
following the completion of the study. 
The intervention group participants were enrolled into an 8-week MBSR program 
consisting of weekly 2.5-hour workshops and one 6-hour session on a weekend midway through 
the course. The MBSR courses were offered by community practitioners with formal 
mindfulness training and who had at least 5 years of experience leading MBSR programs. 
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Materials and methods used are recommended by the Center for Mindfulness, where this method 
was developed (University of Massachusetts).  
In order to evaluate the effect of the intervention, participants in both the control and 
intervention arms completed a series of self-report questionnaires at four points in time: 
immediately after enrolment in the study (T1), after the medical optimization had occurred and 
before the intervention period started (T2), 2 weeks after the group intervention (T3) and 3 
months following the completion of the intervention (T4). 
Measures 
A series of self-report questionnaires were used to collect information about participants’ 
age, gender, employment status, pain duration and diabetes duration. Questionnaires can be seen 
in Appendix B. 
The Brief Pain Inventory (BPI; Cleeland, 1991) is a 32-item questionnaire which assesses 
pain in terms of background characteristics, severity, medication usage and pain interference 
relating to functional disability. The pain interference subscale will be the outcome variable of 
interest. Scores on this scale range from 0 to 10, with higher scores reflecting greater levels of 
pain-related disability in response to seven daily activities: general activity, mood, walking 
ability, work, relations with other people, sleep and enjoyment of life. The average of these 
provides a total interference score. A one point change on the interference scale mean score has 
been recommended by the Initiative on Methods, Measurement and Pain Assessment in Clinical 
Trials guidelines as a reasonable minimal clinically significant change (Dworkin et al., 2008). 
The BPI has been determined to be both valid and reliable in samples with painful diabetic 
peripheral neuropathy (Zelman, Gore, Dukes, Tai, & Brandenburg, 2005), with a Cronbach’s 
alpha coefficient of .94.   
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The Pain Catastrophizing Scale (PCS; Sullivan et al., 1995) which is a well-validated 13-
item instrument designed to evaluate the degree to which patients have negative self-statements 
and catastrophizing thoughts when in pain. The measure consists of 3 subscales of rumination, 
magnification and helplessness but scores can also be totalled for an overall measure of pain 
catastrophizing.  Total PCS scores range from 0 to 52 with higher scores indicating higher pain 
catastrophizing. The subscales have been validated in neuropathic pain patients (Sullivan et al., 
2005) with Cronbach’s alpha coefficients of .85 (rumination), .75 (magnification) and .86 
(helplessness). With good criterion-related validity, the total PCS score has a reliability 
coefficient of .95. 
The Five Facets Mindfulness Questionnaire (FFMQ; Baer et al., 2006) is a 39-item 
instrument measuring five aspects of mindfulness: Non-reactivity to inner experience; observing, 
describing, acting with awareness, and being non-judgmental of experiences. Cronbach’s alpha 
for the subscales range from .75-.91. Additionally, the subscales can be added to create a total 
composite mindfulness score. A review by Park, Reilly-Spong and Gross (2013) demonstrated 
that that the FFMQ had the highest possible rating in internal consistency and construct validity 
when compared to several other commonly implemented instruments measuring mindfulness. 
Data Screening and Analyses 
Data was entered into the Statistics and Package for Social Sciences (SPSS Statistics for 
Windows, Version 21.0) and screened for accuracy and outliers. There was less than 1% of data 
missing across patients and all questionnaires. Missing data were imputed backwards or forwards 
from other time points depending on when the missing value occurred. For example, if the 
participant did not complete question 1 at T2, their T1 question 1 score would be imputed 
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forward. Data was not imputed across the intervention. There were no detected issues in terms of 
normality, linearity, and multicollinearity among the independent variables.  
In accordance with Preacher and Hayes’ recommendations (2004), a series of regression 
models were constructed based on the findings of the primary study and were used to detect a 
mediating effect of either mindfulness or pain catastrophizing on pain-related disability. The 
PROCESS macro was used to conduct the analysis, which employs a bootstrap method to 
estimate the indirect (or mediating) effect. A test of inference was conducted using bootstrap 
confidence intervals. This has been shown to have additional power compared to previous 
methods using normal theory hypothesis testing which posits unrealistic assumptions of 
normality (Williams & Mackinnon, 2008). Mindfulness and pain catastrophizing were entered in 
a parallel mediator model as this offers additional statistical power and the ability to compare the 
indirect effect sizes of each mediator (Hayes, 2013). Five thousand random samples were created 
from the original data to calculate the indirect effects. In order to understand the impact of the 
intervention on the outcome, the model will include mediators at T3, immediately following the 
intervention. As we are interested in the outcome (pain interference) over a longer period of 
time, we included T4, at 3 month follow up in the mediation model.  
Results 
Descriptive Statistics 
Baseline demographics and relevant variables were similar between groups (Table 1). 
Participants’ ages ranged from 41-79 in the MBSR group and 35-79 in the control group. On 
average, patients experienced diabetes much longer than the duration of their pain. Immediately 
following the intervention (T3) pain catastrophizing appeared to be lower in the MBSR group, 
and mindfulness was higher in the MBSR group as seen in Table 2. Pain interference was lower 
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at 3 month follow up (T4) in the treatment group than the control. The primary analysis 
confirmed the differences between groups were statistically significant between relevant 
measures. 
Table 1. Descriptive Statistics 
  
 All (n=62) 
 
Control (n=32) 
 
MBSR (n=30) 
Characteristic      
Age, years, mean (SD) 59.7 (8.8)  59.8 (8.7)  59.7 (9.1) 
Female, n (%) 35 (56) 
 
20 (62.5) 
 
15 (50) 
Diabetes Type 2, n (%) 48 (77) 
 
24 (75) 
 
24 (80) 
Severe Pain, n (%) 17 (27) 
 
8 (25) 
 
9 (30) 
Pain Duration, years, mean (SD) 7.4 (6.0)  8.0 (6.7)  6.7 (5.2) 
Post-secondary education, n (%) 46 (74) 
 
23 (71.9) 
 
23 (76.7) 
Work status, n (%) 
     Employed 
     Retired 
     Disability  
     Other 
11(17.7) 
33 (53.2) 
15 (24.2) 
3 (4.8) 
 
4 (12.5) 
18 (56.3) 
8 (25) 
2 (6.3) 
  
7 (23.3) 
15 (50) 
7 (23.3) 
1 (3.3) 
 
Preliminary Analysis 
A mixed effects logistic regression analysis from Howard et al. (under review) confirmed 
their primary hypothesis that those in the MBSR group, the majority of patients (63.3%) 
experienced clinically important decrease in pain interference by 1 point or greater from the time 
of randomization to T4 (3 month follow up). Fewer participants in the control group saw a 
reduction in pain interference (21.9%) and this was a statistically significant difference (p = 0.02, 
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95% CI = 1.5, 63.8). Furthermore, the MBSR group also saw a 46.5% reduction in pain 
catastrophizing from randomization to follow up, post-intervention (p <0.01, CI = -17.18, -7.52). 
Table 2.  Means and Standard Deviations of Pain Catastrophizing (PCS, Total Score), 
Mindfulness (FFMQ, Total Mean Score), and Pain Interference (BPI, Interference Subscale) at 
various time points 
 
 
MBSR 
(N = 30) 
 Control     
(N = 32) 
  Variable Mean (SD)  Mean (SD) 
 Pain Catastrophizing  23.4 (11.9)  27.6 (12.1) 
T1 Mindfulness 3.3 (0.6)  3.32 (0.6) 
 Pain Interference 4.9 (2.0)  4.83 (2.4) 
 Pain Catastrophizing  22.0 (11.6)  23.9 (12.2) 
T2 Mindfulness 3.4 (0.5)  3.4 (0.6) 
 Pain Interference 4.9 (2.1)  4.6 (2.5) 
 Pain Catastrophizing  14.8 (10.9)  24.6 (12.0) 
T3 Mindfulness 3.6 (0.4)  3.3 (0.5) 
 Pain Interference 4.0 (2.4)  5.2 (2.3) 
 Pain Catastrophizing 11.3 (10.4)  25.6 (10.6) 
T4 Total Mindfulness 3.7 (0.5)  3.2 (0.4) 
 Pain Interference 3.2 (2.1)  5.1 (2.4) 
 
Correlation Analysis 
 A series of point-biserial correlations were calculated to analyze the relationships 
between group (dichotomous) and relevant variables at different time points. As can be seen in 
Table 3, group assignment to either the MBSR or wait-list control group was moderately related 
to pain catastrophizing post-intervention, T3 (rpb = .40, p= 0.001), total mindfulness post-
intervention, T3 (rpb = -.34, p =0.006) and pain interference at 3 month follow up, T4               
(rpb = -0.39, p = 0.002). In other words, following the intervention, being assigned to the wait-list 
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control group meant you were more likely to be higher in pain catastrophizing, pain interference 
and lower mindfulness. There were no significant relationships between group assignment and 
baseline characteristics.  
With consideration to the proposed mediation model (Figure 1), possible mediators were 
found to be correlated with the outcome measure. Bivariate Pearson correlations indicated that 
total mindfulness (r = -0.39, p = 0.002) and pain catastrophizing (r = 0.37, p = 0.003) 
immediately following the intervention period (T3) were both significantly related to pain 
interference at 3 month follow up (T4). These relationships provided further evidence to explore 
possible mediators between participating in the MBSR program and pain interference. 
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Table 3. Correlations between pain catastrophizing, total mindfulness, pain interference and intervention group at various time points 
(N = 62). 
    Measure 1 2 3 4 5 6 7 8 9 
1. Intervention Arm1 -         
2. Pain Interference (V2) -0.07 -        
3. Pain Interference (V3) 0.25 0.72** -       
4. Pain Interference (V4) 0.39** 0.56** 0.77** -      
5. Total Mindfulness (V2) -0.01 -0.24 -0.24 -0.14 -     
6.Total Mindfulness (V3) -0.34** -0.22 -0.41** -0.39** 0.72** -    
7. Total Mindfulness (V4) -0.46** -0.18 -0.35** -0.37** 0.51** 0.79** -   
8. Pain Catastrophizing (V2) 0.08 0.45** 0.34** 0.27* -0.18 -0.15 -0.11 -  
9. Pain Catastrophizing (V3) 0.40** 0.40** 0.41** 0.37** -0.29* -0.41** -0.41** 0.67** - 
10. Pain Catastrophizing (V4) 0.57** 0.34** 0.40** 0.55** -0.12 -0.40** -0.51** 0.52** 0.72** 
1 Intervention arm, 0 = MBSR group, 1 = Wait-list control group     
* p < .05       
** p< .01       
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Mediation Analysis 
The PROCESS macro (Hayes, 2013) was used to perform a mediation regression analysis 
and to investigate the hypothesis that pain catastrophizing and mindfulness mediated the effects 
of a mindfulness-based stress reduction program and pain interference. A mediation analysis was 
conducted using ordinary least squares path analysis showing that participating in MBSR 
indirectly influenced pain-related disability through its effect on mindfulness, whereas there was 
no indirect effect of pain catastrophizing. Figure 1 demonstrates the relationships between 
intervention group, mediators and outcome. 
Age, gender and baseline characteristics (T2) were controlled for within this model, 
which entered both mediators in parallel. The bootstrap bias-corrected confidence intervals 
indicate with 95% confidence that treatment group influences pain-related disability indirectly 
through mindfulness [unstandardized regression coefficient (B) = 0.55; SE = 0.32; 95% CI = 
0.06, 1.35], but not pain catastrophizing (B = - 0.17; SE = 0.31; 95% CI = - 0.90 to 0.37) as the 
confidence interval contains zero. 
When analyzing the individual relationships within the model, as predicted, pathways 
between the predictor (group), and each respective mediator were significant, as seen in Figure 
1. In satisfying the assumptions required for mediation to occur, mindfulness significantly 
predicted pain interference (b2) but pain catastrophizing was not a significant predictor (b1). 
Finally, there was a significant direct effect of intervention group on pain-related disability (c’ = 
1.68, p = 0.005). As such, the primary hypothesis that mindfulness influences the relationship 
between participating in MBSR and pain-related disability through a mediating effect was 
supported, whereas pain catastrophizing was not a significant mediator. 
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Figure 1. Statistical diagram showing coefficients of mediation model. 
 
                             * p < .05 
                           ** p < .01 
                          ***p < .001 
 
            
 
  
Pain 
Catastrophizing
Pain 
Interference
Mindfulness
Group
a1= 9.08*** 
b1= -0.02 
b2 =-1.63* a2=- 0.34*** 
c l = 1.68 ** 
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Discussion 
Nathan and colleagues (under review) recently completed a randomized controlled trial 
comparing the effects of a mindfulness-based stress reduction (MBSR) program to a wait-list 
control group in patients with painful diabetic peripheral neuropathy. The primary goal of the 
present study was to further explain Nathan et al.’s primary analyses’ finding that compared to 
patients who were assigned to a wait-list control condition, patients with painful peripheral 
diabetes neuropathy who participated in the MBSR intervention (MBSR) experienced a 
significantly greater reduction in pain-related disability.  
To situate our findings among the existing literature, the group means were found to be 
comparable to other studies employing the same measures. Pain catastrophizing and pain-related 
disability were higher in the control group than treatment following the intervention period, but 
the means were comparable to previous studies which looked at similar relationships (Schütze et 
al., 2010) and the control group was higher in pain catastrophizing than other neuropathic 
samples that have been analyzed (Poulin et al., 2016). It should be noted that neither the pain 
catastrophizing average for the MBSR group (M = 14.8, SD = 10.9) and the control group (M = 
34.6, SD = 12.4) fall within what Sullivan (1995) deems to be a clinically relevant level of 
catastrophizing. Mindfulness at follow up in the control group was lower than Poulin et al.’s 
(2016) study looking at cancer survivors with neuropathic pain (M = 3.3, SD = 0.5). At the same 
point in time, the MBSR group’s mindfulness score was higher (M = 3.6, SD = 0.4). 
It was hypothesized that the effect of MBSR on pain-related disability would occur 
through two possible psychological mechanisms. Both increased mindfulness and lower pain 
catastrophizing were expected to explain the relationship between treatment group and pain-
related disability, respectively. While mindfulness was found to be a mediator between 
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intervention group and pain-related disability, pain catastrophizing was not. One possible 
explanation for failing to detect a mediating effect may be that baseline characteristics of both 
catastrophizing and pain interference are greater predictors of pain interference following an 
MBSR intervention than the intervention itself.  
An alternative explanation for the absence of the mediating effect of pain catastrophizing 
may be due small sample size.  The primary study (Nathan et al., in preparation) was not 
designed for the purposes of a mediation analysis. It is possible that testing the relationships with 
a larger sample size would allow an effect of pain catastrophizing to be seen. This is further 
evident through a post-hoc evaluation of the mediation analyses power. Given the mediation 
effect observed, based on guidelines from Fritz and MacKinnon (2007), the pain catastrophizing 
pathway would require a sample size of 396 to achieve 0.80 power. The effect of mindfulness 
was sufficiently large to be statistically detected; the sample size required to achieve 0.80 power 
in this case was 53. This may indicate why the study was able to detect an effect of one but not 
the other. Further analysis with a larger is sample size is necessary to further understand the 
nature of pain catastrophizing’s relationship and relevance to clinical outcomes, following 
participation in a mindfulness-based stress reduction program. A larger sample would also allow 
for assessing the relative contribution of various aspects of pain catastrophizing and facets of 
mindfulness.  
Although evidence has made comparisons between mindfulness and pain catastrophizing 
acting at opposite ends of the spectrum of how attention is controlled in relation to pain (Cassidy 
et al., 2012; Schütze et al., 2010),  they are not opposing factors. While they were related to each 
other at baseline and following the intervention, the strength of the negative relationship 
observed between the two was only moderate. As such, one can have increased mindfulness and 
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regardless of whether they have tendencies to catastrophize about their pain, they will experience 
less pain-related disability following the intervention.  
Smeets, Vlaeyen, Kester and Knottnerus (2006) and Turner, Holtzman and Mancl (2007) 
both found that pain catastrophizing mediates pain-related disability in cognitive behavioural-
based treatments for musculoskeletal chronic pain conditions. This difference in findings may 
highlight respective mechanisms of improvement in pain-related disability, in that MBSR 
improves function through increased mindfulness, impacting participants’ ability to remain 
aware, decentered and in the present moment. Cognitive behavioural therapy, on the other hand 
may function through its ability to teach control over thought patterns and actively attempting to 
alter maladaptive thoughts that may lead to catastrophizing cognitions.  
Mindfulness is related to both pain-related disability and catastrophizing, as such, it may 
represent a third variable that minimizes the relationship between the two when statistically 
accounted for.  Mindfulness encourages a decentering, accepting attitude towards thoughts as 
they arrive. As catastrophic cognitions would be accepted in this frame of mind, those with 
tendencies to catastrophize may continue to do so despite increased mindfulness. The goal of 
MBSR programs is not to control one’s thoughts, but rather become more accepting of them 
(Kabat-Zinn, 1982).  
 Contrary to catastrophizing, mindfulness was a significant mediator between participating 
in MBSR and pain-related disability. In other words, the relationship between participating in 
MBSR and pain-related disability is influenced by an individual’s level of mindfulness following 
the intervention, while taking into account participants’ baseline characteristics (mindfulness, 
pain catastrophizing and pain-interference), in addition to age and gender. Mindfulness has been 
shown to consistently increase following participation in MBSR group training (Visted, 
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Vøllestad, Nielsen, & Nielsen, 2015), and these findings demonstrate that the same is true in a 
sample of those with painful diabetic peripheral neuropathy.  
Additionally, the mediating effect of mindfulness on pain-related disability can be 
explained through the impact mindfulness has on individuals’ ability to be aware in the present 
moment, evaluating situations (including painful ones) with non-judgmental and non-reactive 
acceptance.  This may occur through processes which disrupt the recurring fear-avoidance cycle, 
such as self-regulating one’s awareness, particularly in regards to their body, and through 
increasing their acceptance of their pain and symptoms. These findings have clinical 
implications, particularly for those with peripheral diabetic neuropathy. Clinicians treating those 
with neuropathic pain and diabetes may wish to consider mindfulness-based interventions based 
on their ability to reduce pain-related disability. Furthermore, understanding which factors are 
the most influential towards relevant outcomes can help shape the development of future 
interventions to ensure their effectiveness is optimized for a given population.  
Many studies have implied that the statistically significant mediation effect of 
mindfulness on pain-related disability through MBSR would suggest a causal relationship 
between the included variables (Preacher, 2015). However, others have warned to be cautious in 
interpreting the results of mediation analysis (Danner, Hagemann, & Fiedler, 2015; Fiedler, 
Schott, & Meiser, 2011). This is due to the many relationships that have not been tested or 
included in the model that may also be significant. As such, the nature of the presented results 
suggest that increased mindfulness may be one of many possible mechanisms in which MBSR 
programs are effective at reducing pain-related disability.   
 Towards the pursuit of a more comprehensive model which may better explain why 
MBSR is effective at reducing pain-related disability, additional variables should be included in 
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future studies, such as pain-related fear, avoidance, and mood. The findings of this study that 
indicate mindfulness influences pain-related disability over the course of a MBSR program 
support Schutze et al.’s (2010) suggestion that mindfulness is a factor that should be considered 
in the context of the fear-avoidance model of chronic pain as seen in their revised model (Figure 
2). However, as pain catastrophizing was not a mediator between MBSR and pain interference, it 
begs the question that perhaps the fear-avoidance model of chronic pain cannot be applied to 
neuropathic pain conditions in the same way it is to musculoskeletal conditions. Further 
assessment is required. 
Figure 2. Graphical representation from Schutze et al., 2010 integrating mindfulness into the 
fear-avoidance model of chronic pain (Adapted from Vlaeyen & Linton, 2000). 
  
 
Future research in this domain should aim to assess these variables at additional time 
points. By measuring relevant constructs at various times, sequential analysis can be conducted 
(Hayes, 2013). In other words, it could be determined if changes in mindfulness preceded 
changes in other fear-avoidance model variables, and their relationship with outcomes like pain-
MINDFULNESS 
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related disability. Although possible with Hayes’ mediation analysis (2013), moving towards 
more sophisticated and robust methods such as structural equation modeling, more complex 
models can be represented and tested (Cook et al., 2006). This would provide a comprehensive 
understanding of the factors involved in pain-related disability over the course of a mindfulness-
based interventions. 
Additionally, using structural equation modelling would allow future studies to include 
individual facets of mindfulness simultaneously when looking at different outcomes during 
MBSR. Recently, Poulin et al. (2016) found that being non-judgmental and acting with 
awareness were most consistently related to pain-related outcomes. Day, Smitherman, Ward and 
Thorn (2015) investigated the relationships between mindfulness and catastrophizing. They 
concluded that the two constructs were moderately related and that each facet was a predictor of 
catastrophizing, although this was not the case when ‘worry’ was controlled for. This further 
highlights the complex nature of the relationship between mindfulness, pain catastrophizing and 
the fear-avoidance model, encouraging researchers to determine which factors are most 
influential and helpful to patients in reducing disability and improving quality of life. 
Additionally, examining these relationships in a temporal perspective may prove useful for 
intervention development to determine the aspects of an intervention that are effective at 
different points in time. 
Conclusion 
The present study investigated two possible mediators which may explain why MBSR is 
effective at reducing pain-related disability. Although the results must be interpreted with 
consideration to small sample size and a limited number of time points preventing the use of 
more sophisticated analytical methods, the current study found that mindfulness was a significant 
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mediator of MBSR effects on pain-related disability while pain catastrophizing was not. This 
study represents a step forward in the literature through its use of data from a randomized control 
trial design and as well as recommended mediation analysis methodology that increases power 
(Preacher and Hayes, 2004; Hayes, 2013) compared to previous traditional methods (Baron & 
Kenny, 1986). Additionally, we have looked at these mediating relationships in a previously 
untested population of those with painful peripheral diabetic neuropathy. Understanding how 
pain and its’ effect on disability can be impacted by MBSR and mindfulness can have 
implications for those with neuropathic forms of pain. Further research is warranted to determine 
how MBSR impacts different variables within the fear-avoidance model which may influence 
disability.  
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Appendix A: CONSORT Flow Diagram 
 
 
  Assessed for eligibility (n= 255)  
) 
Excluded  (n=  189 ) 
VAS not returned (n= 106) 
VAS < 4 (n= 15 ) 
Did not attend first visit (n = 26) 
Medically unable to participate (n = 8) 
Refused to consent (n = 4) 
Withdrew before randomization (n = 7) 
Study end (n = 8) 
Other (n = 15) 
 
Analysed  (n= 30 ) 
 Excluded from analysis (screen failure, n= 1) 
Completed 2 week follow-up (n = 31) 
Completed 3 month follow-up (n = 31) 
Allocated to intervention (n= 33  ) 
 Received allocated intervention (n= 31  ) 
 Did not attend any classes (n= 2 ) 
Completed 2 week follow-up (n = 32) 
Completed 3 month follow-up (n = 32) 
 
Allocated to wait list  (n= 33 ) 
 Received allocated intervention (n= 32 ) 
 Withdrew from study (n= 1 ) 
Analysed  (n= 32  ) 
 Excluded from analysis (n= 0  ) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n= 66 ) 
Enrollment 
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Appendix B: Questionnaires 
 
 
 
 
 
 
 
 
 
  
ID:   Today’s Date:   
 
Coping with Chronic Pain Survey 
 
To help us understand your current situation, please complete the following as fully as possible. 
 
 
1. Where do you experience the most pain? Please check (  ) only one. 
 [   ] Head, face, mouth [   ] Lower back, lumbar spine 
 [   ] Neck (cervical) region [   ] Legs, feet 
 [   ] Shoulders [   ] Pelvic region 
 [   ] Arms, hands [   ] Genital region (private parts) 
 [   ] Chest [   ] Joints 
 [   ] Abdominal region [   ] All over body 
 [   ] Upper back [   ] Other (please specify)   
 
 
2. How long have you had pain?   (approximate start date) 
 
 
Please tell us a little about yourself: 
 
 
3. What is your age? _______ 4. What is your gender? [   ] male [   ] female 
 
 
5. What is your current marital or relationship status? 
 [   ] Single (include separated, divorced or widowed) 
 [   ] Married or [   ] Living with partner; How long?   (years) 
 
 
6. What is your current employment status? (please check the single most representative) 
 ____ Full-time ____ Other (please specify) ________________________ 
 ____ Part-time 
 ____ Unemployed 
  ____ Student  
 
 
7. In broad terms, how would you categorize your ethnic background? 
 [   ] Caucasian origin [   ] African origin 
 [   ] First Nations origin [   ] Other (please specify)   
 [   ] Asian origin 
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FFMQ 
Please rate each of the following statements using the scale provided. Circle the number that best describes your 
own opinion of what is generally true for you. 
Please indicate below 
N
ev
er
 o
r 
ra
re
ly
 tru
e 
   
V
er
y
 o
ften
/ 
a
lw
a
y
s tru
e
 
1. I perceive my feelings and emotions without having to react to them. 1 2 3 4 5 
2. When I’m walking, I deliberately notice the sensation of my body moving. 1 2 3 4 5 
3. I find it difficult to stay focused on what’s happening in the present. 1 2 3 4 5 
4. I’m good at finding the words to describe my feelings. 1 2 3 4 5 
5. I criticize myself for having irrational or inappropriate emotions. 1 2 3 4 5 
6. I watch my feeling without getting lost in them. 1 2 3 4 5 
7. I notice how foods and drinks affect my thoughts, bodily sensations, and 
emotions. 
1 2 3 4 5 
8. I pay attention to how my emotions affect my thoughts and behaviours. 1 2 3 4 5 
9. When I take a shower or a bath, I stay alert to the sensations of water on my 
body. 
1 2 3 4 5 
10. It seems I am “running on automatic” without much awareness of what I’m 
doing. 
1 2 3 4 5 
11. I can easily put my beliefs, opinions, and expectations into words. 1 2 3 4 5 
12. I tell myself that I shouldn’t be feeling the say I’m feeling. 1 2 3 4 5 
13. In difficult situations, I can pause without immediately reacting. 1 2 3 4 5 
14. I pay attention to sensations, such as the wind in my hair or sun on my face. 1 2 3 4 5 
15. I rush through activities without being really attentive to them. 1 2 3 4 5 
16. It’s hard for me to find words to describe what I’m thinking. 1 2 3 4 5 
17. I believe some of my thoughts are abnormal or bad and I shouldn’t think 
them. 
1 2 3 4 5 
18. When I have distressing thoughts or images, I am able to just notice them 
without reacting. 
1 2 3 4 5 
19. I pay attention to sounds, such as clocks ticking, birds chirping, or cars 
passing. 
1 2 3 4 5 
20. I do jobs or tasks automatically, without being aware of what I’m doing. 1 2 3 4 5 
21. I have trouble thinking of the right words to express how I feel about things. 1 2 3 4 5 
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N
ev
er
 o
r 
ra
re
ly
 tru
e 
   
V
er
y
 o
ften
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e
 
22. I make judgements about whether my thoughts are good or bad. 1 2 3 4 5 
23. When I have distressing thoughts or images, I feel calm soon after. 1 2 3 4 5 
24. I find myself doing things without paying attention. 1 2 3 4 5 
25. When I have a sensation in my body, it’s hard for me to describe it because I 
can’t find the right words. 
1 2 3 4 5 
26. I tell myself I shouldn’t be thinking the way I’m thinking. 1 2 3 4 5 
27. When I have distressing thoughts or images, I “step back” and am aware of 
the thought or image without getting taken over by it. 
1 2 3 4 5 
28. I notice the smells and aromas of things. 1 2 3 4 5 
29. When I do things, my mind wanders off and I’m easily distracted. 1 2 3 4 5 
30. Even when I’m feeling terribly upset, I can find a way to put it into words. 1 2 3 4 5 
31. I think some of my emotions are bad or inappropriate and I shouldn’t feel 
them. 
1 2 3 4 5 
32. Usually when I have distressing thoughts or images, I just notice them and let 
them go. 
1 2 3 4 5 
33. I can usually describe how I feel at the moment in considerable detail. 1 2 3 4 5 
34. I don’t pay attention to what I’m doing because I’m daydreaming, worrying 
or otherwise distracted. 
1 2 3 4 5 
35. I disapprove of myself when I have irrational ideas. 1 2 3 4 5 
36. I notice visual elements in art or nature, such as colors, shapes, textures, or 
patterns of light and shadow. 
1 2 3 4 5 
37. I am easily distracted. 1 2 3 4 5 
38. My natural tendency is to put my experiences into words. 1 2 3 4 5 
39. Usually when I have distressing thoughts or images, I judge myself as good 
or bad, depending on what the thought/image is about. 
1 2 3 4 5 
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 PCS Scale 
Using the following scale, please indicate the degree to which you have these thoughts and feelings when you 
are experiencing pain. “When I’m in pain…” 
 
Not at 
all 
To a 
slight 
degree 
To a 
moderate 
degree 
To a 
great 
degree 
All the 
time 
I worry all the time about whether the pain will end. 0 1 2 3 4 
I feel I can’t go on. 0 1 2 3 4 
It’s terrible and I think it’s never going to get any better. 0 1 2 3 4 
It’s awful and I feel that it overwhelms me. 0 1 2 3 4 
I feel I can’t stand it anymore. 0 1 2 3 4 
I become afraid that the pain will get worse. 0 1 2 3 4 
I think of other painful events. 0 1 2 3 4 
I anxiously want the pain to go away. 0 1 2 3 4 
I can’t seem to keep it out of my mind. 0 1 2 3 4 
I keep thinking about how much it hurts. 0 1 2 3 4 
I keep thinking about how badly I want the pain to stop. 0 1 2 3 4 
There is nothing I can do to reduce the intensity of the pain. 0 1 2 3 4 
I wonder whether something serious may happen. 0 1 2 3 4 
 
